J. Delattre

1.3k total citations
46 papers, 1.0k citations indexed

About

J. Delattre is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Delattre has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in J. Delattre's work include Glioma Diagnosis and Treatment (23 papers), Brain Metastases and Treatment (10 papers) and Cancer, Hypoxia, and Metabolism (5 papers). J. Delattre is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Brain Metastases and Treatment (10 papers) and Cancer, Hypoxia, and Metabolism (5 papers). J. Delattre collaborates with scholars based in France, Netherlands and Switzerland. J. Delattre's co-authors include Khê Hoang‐Xuan, Marc Sanson, Karima Mokhtari, Y. Marie, Alain Carpentier, Sophie Taillibert, Philippe Broët, Emmanuelle Crinière, M. Kujas and Philippe Cornu and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Oncogene.

In The Last Decade

J. Delattre

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Delattre France 16 647 312 263 198 198 46 1.0k
Kiyoshi Onda Japan 16 464 0.7× 198 0.6× 186 0.7× 180 0.9× 71 0.4× 38 832
Eric Burton United States 14 404 0.6× 205 0.7× 207 0.8× 104 0.5× 148 0.7× 41 784
Yuriko Minn United States 4 578 0.9× 233 0.7× 341 1.3× 167 0.8× 227 1.1× 5 997
Alessia Pellerino Italy 18 641 1.0× 322 1.0× 259 1.0× 110 0.6× 113 0.6× 73 1.1k
Zhongcheng Wang China 20 305 0.5× 142 0.5× 229 0.9× 163 0.8× 109 0.6× 74 1.1k
Takafumi Ide Japan 14 237 0.4× 146 0.5× 281 1.1× 179 0.9× 119 0.6× 33 797
Mark Rosenblum United States 13 387 0.6× 504 1.6× 474 1.8× 150 0.8× 160 0.8× 17 1.8k
Dariusz J. Jaskólski Poland 17 286 0.4× 105 0.3× 286 1.1× 175 0.9× 201 1.0× 96 962
M. Lahutte France 10 483 0.7× 224 0.7× 339 1.3× 108 0.5× 196 1.0× 28 1.0k
Noemí Vidal Spain 19 230 0.4× 109 0.3× 263 1.0× 144 0.7× 64 0.3× 65 936

Countries citing papers authored by J. Delattre

Since Specialization
Citations

This map shows the geographic impact of J. Delattre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Delattre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Delattre more than expected).

Fields of papers citing papers by J. Delattre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Delattre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Delattre. The network helps show where J. Delattre may publish in the future.

Co-authorship network of co-authors of J. Delattre

This figure shows the co-authorship network connecting the top 25 collaborators of J. Delattre. A scholar is included among the top collaborators of J. Delattre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Delattre. J. Delattre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duplan, Eric, Thomas Goiran, Y. Marie, et al.. (2013). Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity. Oncogene. 33(14). 1764–1775. 57 indexed citations
2.
Bent, Martin J. van den, Alba A. Brandes, Martin Taphoorn, et al.. (2012). LONG TERM FOLLOW-UP RESULTS OF EORTC 26951: A RANDOMIZED PHASE III STUDY ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS - A REPORT OF THE EORTC BRAIN TUMOR GROUP. Neuro-Oncology. 14. 12–12.
3.
Chinot, Olivier, Khê Hoang‐Xuan, Michel Fabbro, et al.. (2011). TEMOBIC: A ANOCEF phase II study of BCNU and temozolomide (TMZ) combination prior to radiotherapy (RT) in anaplasic oligodendroglial gliomas (AOG).. Journal of Clinical Oncology. 29(15_suppl). 2034–2034. 2 indexed citations
4.
Dehais, Caroline, et al.. (2011). Évaluation de la fatigue dans les glioblastomes en récidive traités par l’association irinotécan-bévacizumab. Revue Neurologique. 167(11). 841–846. 3 indexed citations
5.
Ursu, Rénata, et al.. (2008). Méningite chronique à méningocoque de l’adulte. Revue Neurologique. 165(6-7). 605–609. 1 indexed citations
6.
Delattre, J.. (2006). Introduction. Annales Pharmaceutiques Françaises. 64(6). 363–363. 4 indexed citations
7.
Bent, Martin J. van den, J. Delattre, Martin Taphoorn, et al.. (2005). First analysis of EORTC trial 26951, a randomized phase III study of adjuvant PCV chemotherapy in patients with highly anaplastic oligodendroglioma. Journal of Clinical Oncology. 23(16_suppl). 1503–1503. 20 indexed citations
8.
Hoang‐Xuan, Khê, L. Capelle, M. Kujas, et al.. (2004). Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions. Journal of Clinical Oncology. 22(15). 3133–3138. 272 indexed citations
9.
Leuraud, Pascal, Luc Taillandier, Lucinda Aguirre‐Cruz, et al.. (2003). Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. British Journal of Cancer. 89(12). 2327–2332. 14 indexed citations
10.
11.
Bonnefont‐Rousselot, Dominique, Patrice Thérond, Jean‐Louis Beaudeux, et al.. (2001). [Aging and oxidative stress. Which potential markers?].. PubMed. 59(4). 453–9. 15 indexed citations
12.
Lafitte, C, Zahir Amoura, P. Cacoub, et al.. (2001). Neurological complications of primary Sjögren's syndrome. Journal of Neurology. 248(7). 577–584. 127 indexed citations
13.
Sanson, Marc, Mariasanta Napolitano, Ricardo Yayá, et al.. (2000). Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study. Journal of Neuro-Oncology. 50(3). 245–249. 37 indexed citations
14.
Feuvret, L., Isabelle Germain, Philippe Cornu, et al.. (1998). Intérêt de la radiothérapie en conditions stéréotaxiques (radiochirurgie) des métastases cérébrales: expérience et résultats du groupe hospitalier Pitié-Salpêtrière. Cancer/Radiothérapie. 2(3). 272–281. 5 indexed citations
15.
Améri, Alain, M Poisson, L. Chauveinc, Qianming Chen, & J. Delattre. (1997). Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. Journal of Neuro-Oncology. 32(2). 155–160. 21 indexed citations
16.
Lamproglou, Ioannis, Roger Vranckx, J. Delattre, et al.. (1997). Dysfonctionnement cognitif radio-induit chez le rat Wistar mâle âgé de 4 mois. Cancer/Radiothérapie. 1(4). 323–327. 3 indexed citations
17.
Chauveinc, L., Thierry Faillot, Philippe Cornu, et al.. (1996). Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas. Journal of Neuro-Oncology. 27(2). 141–7. 14 indexed citations
18.
19.
Bonnefont‐Rousselot, Dominique, et al.. (1995). [Study of oxidative stress in the elderly].. PubMed. 24(24). 1115–8. 15 indexed citations
20.
Bonnefont‐Rousselot, Dominique, et al.. (1995). Hydroxyl Radical Attack of Low-Density Lipoprotein Decreases Its Cellular Catabolism in the Absence of Significant Lipid Peroxidation. Biochemical and Biophysical Research Communications. 208(2). 597–602. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoshi Onda Breakdown of academic impact, for papers by Eric Burton Breakdown of academic impact, for papers by Yuriko Minn Breakdown of academic impact, for papers by Alessia Pellerino Breakdown of academic impact, for papers by Zhongcheng Wang Breakdown of academic impact, for papers by Takafumi Ide Breakdown of academic impact, for papers by Mark Rosenblum Breakdown of academic impact, for papers by Dariusz J. Jaskólski Breakdown of academic impact, for papers by M. Lahutte Breakdown of academic impact, for papers by Noemí Vidal
Rankless by CCL
2026